Sorafenib in the management of metastatic renal cell carcinoma

PURPOSE: Sorafenib represents one of the two standards of care for patients with metastatic renal cell carcinoma (mrcc). In the present review, we provide information regarding the use of sorafenib in first and second lines. We also describe results for dose escalation strategies. Finally, we provid...

Full description

Saved in:
Bibliographic Details
Main Authors: Guevremont, C., Jeldres, C., Perrotte, P., Karakiewicz, P.I.
Format: Artigo
Language:Inglês
Published: Multimed Inc. 2009
Subjects:
Urologic Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2687798/
https://ncbi.nlm.nih.gov/pubmed/19478894
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items